Hsbc Holdings PLC Sells 3,489 Shares of PRA Health Sciences Inc (NASDAQ:PRAH)

Hsbc Holdings PLC lessened its holdings in PRA Health Sciences Inc (NASDAQ:PRAH) by 46.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,016 shares of the medical research company’s stock after selling 3,489 shares during the period. Hsbc Holdings PLC’s holdings in PRA Health Sciences were worth $369,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in PRAH. Securian Asset Management Inc increased its position in PRA Health Sciences by 1.4% during the fourth quarter. Securian Asset Management Inc now owns 7,171 shares of the medical research company’s stock worth $659,000 after purchasing an additional 100 shares during the last quarter. BB&T Securities LLC increased its position in PRA Health Sciences by 3.5% during the fourth quarter. BB&T Securities LLC now owns 4,240 shares of the medical research company’s stock worth $389,000 after purchasing an additional 145 shares during the last quarter. D.A. Davidson & CO. increased its position in PRA Health Sciences by 5.7% during the fourth quarter. D.A. Davidson & CO. now owns 2,698 shares of the medical research company’s stock worth $248,000 after purchasing an additional 146 shares during the last quarter. State of Alaska Department of Revenue grew its stake in PRA Health Sciences by 2.1% during the fourth quarter. State of Alaska Department of Revenue now owns 7,134 shares of the medical research company’s stock worth $656,000 after buying an additional 150 shares during the period. Finally, Jaffetilchin Investment Partners LLC grew its stake in PRA Health Sciences by 3.6% during the fourth quarter. Jaffetilchin Investment Partners LLC now owns 5,126 shares of the medical research company’s stock worth $471,000 after buying an additional 177 shares during the period. 98.14% of the stock is currently owned by institutional investors.

NASDAQ PRAH traded up $0.34 during trading hours on Friday, reaching $94.47. 627,649 shares of the company traded hands, compared to its average volume of 532,444. PRA Health Sciences Inc has a 12 month low of $79.20 and a 12 month high of $121.98. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.87 and a quick ratio of 0.87. The company has a market capitalization of $6.19 billion, a price-to-earnings ratio of 24.04, a price-to-earnings-growth ratio of 1.36 and a beta of 1.12.

PRAH has been the subject of several research reports. BidaskClub downgraded shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a research note on Thursday, December 27th. SunTrust Banks boosted their price objective on shares of PRA Health Sciences to $120.00 and gave the stock an “average” rating in a research note on Monday, March 4th. ValuEngine upgraded shares of PRA Health Sciences from a “hold” rating to a “buy” rating in a research note on Monday, February 4th. Robert W. Baird boosted their price objective on shares of PRA Health Sciences from $119.00 to $122.00 and gave the stock an “outperform” rating in a research note on Thursday, February 28th. Finally, Zacks Investment Research downgraded shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a research note on Wednesday, January 2nd. One analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the stock. PRA Health Sciences currently has a consensus rating of “Hold” and an average target price of $113.22.

TRADEMARK VIOLATION WARNING: This piece was published by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/pra-health-sciences-inc-prah-position-lowered-by-hsbc-holdings-plc.html.

About PRA Health Sciences

PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.

See Also: What is the QQQ ETF?

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.